|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03347 TIGERMED
Nominal 
44.450 +2.350 (+5.582%) | 2023/06 - Interim RMB(K¥) | %Chg (Interim to Interim) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | 2019/06 RMB(K¥) | ||
| Turnover | 3,710,850 | 3.245% | 3,594,209 | 2,056,375 | 1,451,994 | 1,328,164 | |
| Cost of Sales | (2,244,568) | 3.157% | (2,175,881) | (1,089,456) | (753,880) | (710,197) | |
| Gross Profit | 1,466,282 | 3.381% | 1,418,328 | 966,919 | 698,114 | 617,967 | |
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (29,777) | 4.808% | (28,411) | (10,252) | (5,811) | (1,867) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | (590) | -- | |
| Share of Results of Asso. & JCEs | 63,724 | 79.222% | 35,556 | 723 | (4,269) | (14,048) | |
| Profit / (Loss) before Taxation | 1,599,145 | 8.060% | 1,479,865 | 1,697,716 | 1,139,398 | 625,241 | |
| Taxation | (191,055) | 17.761% | (162,239) | (103,533) | (90,400) | (51,899) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (19,753) | -84.276% | (125,622) | (334,269) | (37,121) | (62,418) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 1,388,337 | 16.471% | 1,192,004 | 1,259,914 | 1,011,877 | 510,924 | |
| Net Finance Costs / (Income) | (70,049) | -15.177% | (82,583) | (126,419) | 11,375 | 15,521 | |
| Depreciation & Amortisation | 162,099 | 32.030% | 122,774 | 88,609 | 70,832 | 45,382 | |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A | |
Market Valuation Indicators
| EPS (cts) | 161.000 | -- | 138.000 | 145.000 | 136.000 | 69.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 23.657 | -- | 21.441 | 19.577 | -- | -- |
| Remarks: | Real time quote last updated: 27/09/2023 10:10 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 1,388,337 |
| %Change | 16.471% |
| EPS / (LPS) | RMB 1.610 |
| NBV Per Share (¥) | RMB 23.657 |